Reaction Details Report a problem with these data
Target
Neuropeptide Y receptor type 2
Ligand
BDBM50197010
Substrate
n/a
Meas. Tech.
ChEMBL_434572 (CHEMBL914219)
EC50
3±n/a nM
Citation
 Lumb, KJ; DeCarr, LB; Milardo, LF; Mays, MR; Buckholz, TM; Fisk, SE; Pellegrino, CM; Ortiz, AA; Mahle, CD Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice. J Med Chem 50:2264-8 (2007) [PubMed]  Article 
Target
Name:
Neuropeptide Y receptor type 2
Synonyms:
NPY-Y2 | NPY-Y2 receptor | NPY2-R | NPY2R | NPY2R_HUMAN | Neuropeptide Y receptor type 2 | Y2 receptor | neuropeptide Y receptor Y2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
42734.65
Organism:
Homo sapiens (Human)
Description:
NPY-Y2 NPY2R HUMAN::P49146
Residue:
381
Sequence:
MGPIGAEADENQTVEEMKVEQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSIILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGPVLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLESKISKRISFLIIGLAWGISALLASPLAIFREYSLIEIIPDFEIVACTEKWPGEEKSIYGTVYSLSSLLILYVLPLGIISFSYTRIWSKLKNHVSPGAANDHYHQRRQKTTKMLVCVVVVFAVSWLPLHAFQLAVDIDSQVLDLKEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCEQRLDAIHSEVSVTFKAKKNLEVRKNSGPNDSFTEATNV
  
Inhibitor
Name:
BDBM50197010
Synonyms:
(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2-aminophenyl)formamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-5-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-carbamoylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-N-[(1S)-4-carbamimidamido-1-{[(1S)-1-carbamoyl-2-(4-hydroxyphenyl)ethyl]carbamoyl}butyl]pentanediamide | CHEMBL227456
Type:
Small organic molecule
Emp. Form.:
C79H121N27O18
Mol. Mass.:
1736.9761
SMILES:
CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)c1ccccc1N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:8.17,67.69,81.83,30.39,101.103,51.53,wD:74.76,75.79,4.4,20.28,92.94,112.114,59.61,(11.01,-29.89,;11.01,-28.35,;12.34,-27.58,;9.68,-27.58,;9.68,-26.04,;8.34,-25.27,;7.01,-26.04,;7.01,-27.58,;5.67,-25.27,;5.67,-23.73,;7.01,-22.96,;8.34,-23.73,;9.67,-22.96,;9.67,-21.42,;11.01,-20.65,;8.33,-20.65,;7,-21.42,;4.34,-26.04,;3.01,-25.27,;3.01,-23.73,;1.67,-26.04,;1.67,-27.58,;3.01,-28.35,;4.48,-27.88,;5.38,-29.14,;4.46,-30.37,;3,-29.88,;.34,-25.27,;-.99,-26.04,;-.99,-27.58,;-2.33,-25.27,;-2.33,-23.73,;-.99,-22.96,;-.99,-21.42,;.34,-20.65,;.34,-19.1,;1.67,-18.33,;-.99,-18.33,;-3.66,-26.04,;-5,-25.27,;-5,-23.73,;-6.33,-26.04,;-6.32,-27.56,;-7.65,-28.34,;-8.99,-27.57,;-8.99,-26.03,;-7.66,-25.26,;-7.66,-23.72,;11.01,-25.27,;11.01,-23.73,;12.34,-26.04,;13.66,-25.25,;13.64,-23.71,;14.97,-22.92,;16.31,-23.67,;14.94,-21.38,;15.01,-26,;15.03,-27.54,;16.33,-25.21,;17.67,-25.96,;17.7,-27.5,;19.04,-28.25,;19.06,-29.79,;20.36,-27.47,;19,-25.17,;18.98,-23.63,;20.34,-25.93,;21.66,-25.14,;21.64,-23.6,;22.97,-22.81,;20.3,-22.85,;23.01,-25.89,;23.03,-27.43,;24.33,-25.1,;25.68,-25.85,;25.7,-27.39,;24.37,-28.18,;27.04,-28.14,;27,-25.06,;26.98,-23.52,;28.34,-25.82,;29.67,-25.03,;29.65,-23.49,;30.97,-22.7,;30.95,-21.16,;32.27,-20.37,;32.25,-18.83,;33.57,-18.04,;30.9,-18.08,;31.01,-25.78,;31.03,-27.32,;32.33,-24.99,;33.68,-25.74,;33.7,-27.28,;35.04,-28.03,;35.06,-29.57,;33.74,-30.36,;36.41,-30.32,;35,-24.95,;34.98,-23.41,;36.34,-25.7,;37.67,-24.92,;37.65,-23.38,;38.97,-22.59,;38.95,-21.05,;40.27,-20.26,;40.25,-18.72,;41.57,-17.93,;38.91,-17.97,;39.01,-25.67,;39.03,-27.21,;40.34,-24.88,;41.68,-25.63,;41.7,-27.17,;43.04,-27.92,;43.06,-29.46,;44.4,-30.21,;45.73,-29.42,;47.07,-30.17,;45.7,-27.87,;44.36,-27.13,;43,-24.84,;44.35,-25.59,;42.98,-23.3,)|
Structure:
Search PDB for entries with ligand similarity: